For investors following Nature's Sunshine Products, Inc. (NATR), the $35 price level has become a magnet for market attention. It is not an arbitrary round number pulled from a chart — it is the consensus 12-month price target shared by the Wall Street analysts who cover the stock. With NATR trading around $20.60 as of late July 2026, reaching $35 would require a gain of roughly 70%. That is a significant move for any small-cap stock, particularly one in the packaged foods and wellness space with a market capitalization of approximately $362 million. The question is not whether $35 appears on analyst spreadsheets, but whether the underlying business can deliver the revenue growth, margin expansion, and strategic execution needed to justify that valuation.
Nature's Sunshine Products, founded in 1972 and headquartered in Lehi, Utah, manufactures and distributes nutritional supplements and personal care products across more than 40 countries. The company operates through four geographic segments — Asia, Europe, North America, and Latin America — and sells its portfolio of over 600 products primarily through a network of independent consultants under the Nature's Sunshine and Synergy Worldwide brands. Product categories span general health, immune support, cardiovascular health, digestive care, personal care, and weight management. With trailing twelve-month revenue of approximately $490 million and roughly 806 employees, NATR is a small but globally diversified player in the dietary supplement industry.
The strongest argument for NATR reaching $35 rests on accelerating fundamental performance. The company delivered record sales of $480.1 million in fiscal 2025, up 5.7% year-over-year, and followed that with a first-quarter 2026 revenue beat of $122.9 million — a 9% increase from the prior year. Earnings per share (EPS) have consistently exceeded analyst expectations, with Q1 2026 EPS of $0.30 coming in 42.9% above the consensus estimate of $0.21. Gross margins have expanded to 73.2%, reflecting supply chain efficiencies and favorable product mix.
Beyond the numbers, the digital transformation story is gaining traction. Management has highlighted that subscription auto-ship programs now account for 47% of North American revenue, and digital sales grew 47% year-over-year in the most recent quarter. CEO Ken Romanzi has articulated a long-term vision to double sales to $1 billion, underpinned by digital expansion, new product launches, and potential M&A. The company also maintains a strong balance sheet with $93.9 million in cash, providing flexibility for strategic investments and share repurchases — NATR has already bought back 18.8% of its shares under its current authorization.
Wall Street coverage of NATR is limited but emphatically bullish. Two firms — DA Davidson and Canaccord Genuity — currently cover the stock with Buy ratings. DA Davidson raised its target from $23 to $33 following Q4 2025 results, citing under-penetrated key markets and a consistent beat-and-raise pattern. Canaccord Genuity, led by analyst Susan Anderson, raised its target twice in quick succession — first from $22 to $29 and then to $37 — pointing to strength across all geographic regions and accelerating digital traction. A third research source, Weiss Ratings, maintains a Hold-equivalent view. The average price target across all three analysts sits at $35, with a high of $37 and a low of $33. No analyst currently rates NATR a Sell.
Model-based fair value estimates independently align near $35, reinforcing the view that this number has analytical substance rather than simply reflecting bullish sentiment.
From a technical analysis perspective, $35 sits well above NATR's 52-week trading range of $12.97 to $28.14. The stock would need to clear the $28 level — its 52-week high — before $35 even enters the conversation. That $28 zone represents the first major resistance area; a decisive breakout above it would signal that momentum has shifted in favor of the bulls. On the downside, support has been established in the $19 to $20 range, roughly where the stock consolidated during mid-2026. The psychological round number of $30 would likely serve as an intermediate milestone and potential resistance point on any sustained move higher. Because NATR is a micro-cap stock with average daily volume around 120,000 shares, price moves can be amplified by limited liquidity, which cuts both ways.
Several factors make the journey to $35 far from guaranteed. First, while NATR has posted consecutive earnings beats, its revenue growth rate remains in the mid-single-digit range, with consensus estimates projecting approximately 3% to 5% top-line growth over the next year. A $35 stock price at current earnings levels would imply a forward P/E multiple above 30x, which represents a significant premium to the current forward P/E of roughly 17x. Achieving that multiple requires sustained execution and confidence that the digital growth narrative is accelerating rather than plateauing.
Second, the May 2026 resignation of CFO L. Shane Jones, while not related to any accounting disagreement according to the company, introduces leadership transition risk at a critical moment. Third, Nature's Sunshine operates in a highly competitive supplement and wellness market dominated by larger players with greater marketing budgets and retail shelf presence. The direct-sales distribution model, while capital-efficient, also faces structural headwinds in an increasingly e-commerce-driven world. Finally, geopolitical risks tied to the company's significant Asia-Pacific exposure — where markets like China, South Korea, Taiwan, and Japan generate a substantial share of revenue — could disrupt growth if trade tensions or regulatory changes emerge.
For traders seeking a data-driven edge in monitoring NATR and thousands of other securities, Tickeron's AI Daily Buy/Sell Signals offer a practical solution. The platform uses artificial intelligence to continuously scan market conditions, technical patterns, and AI-driven analysis, generating actionable Buy, Sell, or Hold signals that adapt as conditions change. Rather than manually tracking every development, traders can use these signals to identify emerging opportunities, stay informed on existing positions, and spot shifting market trends with greater efficiency. Exploring AI-powered signals can help streamline the decision-making process in a market that never stands still.
Can Nature's Sunshine Products realistically reach $35? The building blocks are visible: strengthening financial performance, expanding margins, a credible digital growth story, aggressive share repurchases, and unanimous analyst support all point in the right direction. The company's Q1 2026 results demonstrated that the earnings momentum is not fading, and management's $500 million to $515 million full-year revenue guidance suggests confidence in continued progress.
That said, the distance from $20.60 to $35 is substantial, and closing it would require multiple catalysts firing simultaneously — sustained earnings beats, successful digital channel expansion, continued margin improvement, and a macroeconomic environment that supports small-cap valuations. The stock has never traded at $35, meaning every dollar above $28 would be uncharted territory. Investors should watch the upcoming earnings report in August 2026 for signs of continued momentum, monitor digital sales growth rates as a leading indicator, and pay attention to any update on the CFO succession. The path to $35 exists, but the climb demands both operational excellence and enduring market confidence.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that NATR and BGS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NATR and BGS's prices will move in lockstep.
| Ticker / NAME | Correlation To NATR | 1D Price Change % | ||
|---|---|---|---|---|
| NATR | 100% | -1.18% | ||
| BGS - NATR | 28% Poorly correlated | -1.63% | ||
| JBSS - NATR | 28% Poorly correlated | +0.07% | ||
| CENTA - NATR | 27% Poorly correlated | -1.87% | ||
| LSF - NATR | 25% Poorly correlated | +7.53% | ||
| CENT - NATR | 25% Poorly correlated | -1.60% | ||
More | ||||
| Ticker / NAME | Correlation To NATR | 1D Price Change % |
|---|---|---|
| NATR | 100% | -1.18% |
| Food: Major Diversified industry (62 stocks) | -5% Poorly correlated | -1.62% |